Tech & Gadgets

Most powerful obesity drug yet: People lost up to 25% of weight in trial

31 sec read19 views0 listens

Clinical trials indicate retatrutide, a new obesity medication, enabled participants to lose an average of 25% of their body weight over 80 weeks, with over a third achieving a 30% reduction. This development is significant for the tech and gadget space as it could spur innovation in related health monitoring devices and digital therapeutics designed to support and track such intensive treatment regimens. Expect to see increased integration of these technologies as weight management solutions become more sophisticated.

Read the full article at Ars Technica

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Ali NematiBlogUI.author_articles

BlogUI.view_profile

You Might Like

Cybersecurity1 hour ago27 sec read

The FPGA Chronicles: Open Source It

The APIO open-source toolchain is presented as a way to simplify the use of various FPGA development tools, offering a unified workflow. It functions as an aggregator, integrating components like Yosys and GTKWave and providing a common interface, ev...

Ali Nemati

Cybersecurity1 hour ago27 sec read

5th October - Threat Intelligence Report

Cybersecurity threats continue to escalate with a phishing attack compromising Arizona's state court system, exposing sensitive foster care and protective order records. Separately, South Africa's air navigation provider suffered a ransomware attack ...

Ali Nemati

Cybersecurity1 hour ago25 sec read

Prime Big Deal Days: scammers stock up early as Amazon impersonation attacks nearly triple

Amazon impersonation attacks have surged significantly in advance of major shopping events, with new malicious domains increasing by 42% and overall attacks nearly tripling. This escalating threat landscape, amplified by AI-driven sophistication and ...

Ali Nemati